Scinai Immunotherapeutics Ltd. (SCNI): Shares Outstanding

Annual figures by period end, from SEC filings.

13.87B
As of 2025-12-31
+141.1%
3-year compound annual growth
2021-12-31: 739.05M2022-12-31: 989.29M2023-12-31: 1.86B2024-12-31: 3.41B2025-12-31: 13.87B13.87B
2021-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3113.87B+306.6%2026-04-01, Balance as of period end
2024-12-313.41B+83.7%2026-04-01, Balance as of period end
2023-12-311.86B+87.7%2025-05-07, Balance as of period end
2022-12-31989.29M+33.9%2024-05-15, Balance as of period end
2021-12-31739.05Mn/a2023-04-17, Balance as of period end